[ad_1]
Israeli researchers have discovered a method to tailor specific treatment to lung cancer patients through simple blood tests, reported Monday the Hebrew website "Ynet".
The study, conducted by the Oncology Department of Soroka Hospital in southern Israel, examined the contribution of the use of noninvasive liquid biopsy. "Guardant360" to ensure accurate treatment of patients with metastases.
The Guardant360 test detects DNA segments in the patient's blood from the cancerous tumor or its metastases.
After examining 116 patients with advanced non-small cell lung carcinoma cancer, the study concluded that 65% of patients had a genetic modification that could be treated with US-approved drugs. Food and Drug Administration.
–IANS
m /
(This story has not been changed by Business Standard staff and is generated automatically from a syndicated feed.)
[ad_2]
Source link
